PharVision Advisers’s BlackRock TCP Capital TCPC Stock Holding History
Bought
Maintained
Sold
Other funds holding TCPC
NCM
TCA
CC
PharVision Advisers's TCPC Position: Q1 2026 in Review
PharVision Advisers sold out of BlackRock TCP Capital (TCPC) in Q1 2026, closing a stake of 59,177 shares — an estimated $324K sold.
PharVision Advisers first reported a position in TCPC in Q4 2025 and held it in 1 quarter. The position peaked at $324K in Q4 2025. 117 funds tracked by Wall St. Rank hold TCPC as of Q1 2026.
- PharVision Advisers reported no remaining BlackRock TCP Capital position as of Q1 2026 after selling out during the quarter.
- PharVision Advisers sold 59,177 BlackRock TCP Capital shares in Q1 2026, an estimated $324K.
- PharVision Advisers first reported a position in BlackRock TCP Capital in Q4 2025 and held it in 1 quarter.
- PharVision Advisers's BlackRock TCP Capital position peaked at $324K in Q4 2025.
- 117 funds tracked by Wall St. Rank held BlackRock TCP Capital as of Q1 2026.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.